Basel Medical Group Stock Net Income
| BMGL Stock | 0.49 0.03 5.77% |
Fundamental analysis of Basel Medical allows traders to better anticipate movements in Basel Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Net Loss | -12.1 M | -11.5 M | |
| Net Loss | -12.5 M | -11.9 M | |
| Net Income Per Share | 0.10 | 0.08 | |
| Net Income Per E B T | 0.97 | 0.70 |
Basel | Net Income | Build AI portfolio with Basel Stock |
Basel Medical Group Company Net Income Analysis
Basel Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Basel Medical Net Income | (11.5M) |
Most of Basel Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Basel Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Basel Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Basel Medical is extremely important. It helps to project a fair market value of Basel Stock properly, considering its historical fundamentals such as Net Income. Since Basel Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Basel Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Basel Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Basel Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Basel Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Basel Medical could also be used in its relative valuation, which is a method of valuing Basel Medical by comparing valuation metrics of similar companies.Basel Medical is currently under evaluation in net income category among its peers.
Basel Fundamentals
| Return On Equity | -1.95 | ||||
| Return On Asset | -0.0467 | ||||
| Profit Margin | (1.00) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 10.11 M | ||||
| Shares Outstanding | 18.79 M | ||||
| Shares Owned By Insiders | 54.32 % | ||||
| Shares Owned By Institutions | 1.58 % | ||||
| Number Of Shares Shorted | 199.69 K | ||||
| Price To Book | 2.64 X | ||||
| Price To Sales | 0.81 X | ||||
| Revenue | 12.11 M | ||||
| Gross Profit | 3.18 M | ||||
| EBITDA | (1.13 M) | ||||
| Total Debt | 3.42 M | ||||
| Book Value Per Share | 0.20 X | ||||
| Short Ratio | 1.45 X | ||||
| Earnings Per Share | (0.50) X | ||||
| Number Of Employees | 82 | ||||
| Market Capitalization | 9.77 M | ||||
| Total Asset | 16.85 M | ||||
| Retained Earnings | (4.4 M) | ||||
| Working Capital | 2.43 M | ||||
| Net Asset | 16.85 M |
About Basel Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Basel Medical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Basel Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Basel Medical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Basel Medical Piotroski F Score and Basel Medical Altman Z Score analysis. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. If investors know Basel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Basel Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth 0.322 | Return On Assets | Return On Equity |
The market value of Basel Medical Group is measured differently than its book value, which is the value of Basel that is recorded on the company's balance sheet. Investors also form their own opinion of Basel Medical's value that differs from its market value or its book value, called intrinsic value, which is Basel Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Basel Medical's market value can be influenced by many factors that don't directly affect Basel Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Basel Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Basel Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Basel Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.